血流导向装置治疗Willis环外复杂分叉部动脉瘤:并发症、瘤囊闭塞、吸收、复发及随访中被覆盖分支的改变
本研究回顾了2010年1月至2017年9月间29例患者(14例女性)的30个分叉部动脉瘤,均使用单枚血流导向装置(FD)支架治疗,覆盖35条皮质分支。中位随访显示总体闭塞率82.1%(23/28),永久性致残率3.4%(1/29),死亡及预后不良永久并发症率为0%。MRI显示7/29动脉瘤完全吸收,被覆盖分支闭塞7/35,无症状穿支缺血7/28。
要点
- FD治疗分叉部动脉瘤永久致残率3.4%(1/29),死亡及预后不良永久并发症率为0%。
- 至少2次DSA随访序列的患者闭塞率91.7%(22/24),总体闭塞率82.1%(23/28)。
- 被覆盖的35条分支中7条(20%)闭塞,18条(51.4%)管径减小。
核心结论
- FD治疗分叉部动脉瘤可行,永久致残率和死亡率低,闭塞率高,但可能发生复发。
- 被覆盖皮质分支的管径减小和无症状闭塞以及无症状穿支卒中常见。
- 缺血并发症可能发生,且无可识别的预测因素。
- 作者建议所有患者均应进行MRI随访以评估无症状缺血病灶和动脉瘤囊随时间吸收情况。
研究设计与样本
- 回顾性分析2010年1月至2017年9月间29例患者(14例女性)的30个动脉瘤,均使用单枚FD支架治疗。
- 动脉瘤位置:大脑中动脉分叉部21个,前交通动脉区域8个,胼周动脉分叉部1个。
- 共覆盖35条皮质分支。
- 报告围手术期及迟发性症状性和无症状性并发症,并分析DSA和MRI随访以评估动脉瘤囊和被覆盖分支的改变。
主要发现
- 永久性致残率3.4%(1/29),因被覆盖分支闭塞,末次随访mRS评分为2;死亡率和预后不良(mRS评分>2)的永久并发症率均为0%。
- DSA和MRI平均随访时间分别为21±14.5个月(范围3-66个月)和19±16个月(范围3-41个月)。
- 动脉瘤囊闭塞(包括稳定重塑)的平均时间(24例可评估)为11.8±6个月(中位13个月,范围3-27个月)。
- 总体闭塞率82.1%(23/28),至少2次DSA随访序列组为91.7%(22/24);1例在治疗后41个月发生再通。
- 末次随访时35条被覆盖分支中7条(20%)闭塞,18条(51.4%)管径减小,10条(28.5%)无变化;MRI T2加权序列显示7/29(24.1%)动脉瘤完全吸收,55.2%缩小,17.2%无变化。
关键数值与推荐
- 永久性致残率3.4%(1/29),死亡率0%,预后不良(mRS评分>2)的永久并发症率0%。
- 总体闭塞率82.1%(23/28),至少2次DSA随访序列组91.7%(22/24)。
- 被覆盖分支闭塞7/35(20%),管径减小18/35(51.4%),无变化10/35(28.5%)。
- MRI显示动脉瘤囊完全吸收7/29(24.1%),缩小55.2%,无变化17.2%。
- MRI显示穿支区域无症状缺血7/28(25%),有症状缺血4/28(14.3%),均在24小时内逆转。
临床怎么用
- 作者认为FD治疗分叉部动脉瘤可行,永久致残率和死亡率低,闭塞率高,但可能发生复发。
- 作者指出被覆盖皮质分支的管径减小和无症状闭塞以及无症状穿支卒中常见。
- 作者指出缺血并发症可能发生,且无可识别的预测因素。
- 作者建议所有患者均应进行MRI随访以评估无症状缺血病灶和动脉瘤囊随时间吸收情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study is to present the authors' medium-term results, with special emphasis on complications, occlusion rate of the aneurysm sac (digital subtraction angiography [DSA] and MRI), and the fate of cortical branches and perforating arteries covered ("jailed") by the flow diverter (FD) stent. METHODS: Between January 2010 and September 2017, 29 patients (14 female) with 30 aneurysms were treated with an FD stent. Twenty-one aneurysms were at the middle cerebral artery bifurcation, 8 were in the anterior communicating artery region, and 1 was a pericallosal artery bifurcation. Thirty-five cortical branches were covered. A single FD stent was used in all patients. Symptomatic and asymptomatic periprocedural and delayed complications were reported. DSA and MRI controls were analyzed to evaluate modification of the aneurysm sac and jailed branches. RESULTS: Permanent morbidity was 3.4% (1/29), due to a jailed branch occlusion, with a modified Rankin Scale (mRS) score of 2 at the last follow-up. Mortality and permanent complication with poor prognosis (mRS score > 2) rates were 0%. The mean follow-up time for DSA and MRI (mean ± SD) was 21 ± 14.5 months (range 3-66 months) and 19 ± 16 months (range 3-41 months), respectively. The mean time to aneurysm sac occlusion (available for 24 patients), including stable remodeling, was 11.8 ± 6 months (median 13, range 3-27 months). The overall occlusion rate was 82.1% (23/28), and it was 91.7% (22/24) in the group of patients with at least 2 DSA control sequences. One recanalization occurred at 41 months posttreatment. At the time of publication, at the latest follow-up, 7 (20%) of 35 covered branches were occluded, 18 (51.4%) showed a decreased caliber, and the remaining 10 (28.5%) were unchanged. MRI T2-weighted sequences showed complete sac reabsorption in 7/29 aneurysms (24.1%), and the remaining lesions were either smaller (55.2%) or unchanged (17.2%). MRI revealed asymptomatic and symptomatic ischemic events in perforator territories in 7/28 (25%) and 4/28 (14.3%) patients, respectively, which were reversible within 24 hours. CONCLUSIONS: Flow diversion of bifurcation aneurysms is feasible, with low rates of permanent morbidity and mortality and high occlusion rates; however, recurrence may occur. Caliber reduction and asymptomatic occlusion of covered cortical branches as well as silent perforator stroke are common. Ischemic complications may occur with no identified predictable factors. MRI controls should be required in all patients to evaluate silent ischemic lesions and aneurysm sac reabsorption over time.
引用
- Michelozzi C, Darcourt J, Guenego A, et al. Flow diversion treatment of complex bifurcation aneurysms beyond the circle of Willis: complications, aneurysm sac occlusion, reabsorption, recurrence, and jailed branch modification at follow-up. J Neurosurg. 2018. PMID: 30579280. doi:10.3171/2018.7.JNS18654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。